Single gene mutations that primarily affect pancreatic β-cell function account for
approximately 1–2% of all cases of diabetes. Overlapping clinical features with common …

Abstract Purpose of Review Monogenic forms of diabetes have specific treatments that differ
from the standard care provided for type 1 and type 2 diabetes, making the appropriate …

Aims/hypothesis Current genetic tests for diagnosing monogenic diabetes rely on selection
of the appropriate gene for analysis according to the patient's phenotype. Next-generation …

Monogenic diabetes represents a heterogeneous group of disorders resulting from defects
in single genes. Defects are categorized primarily into two groups: disruption of β‐cell …

Background Diagnosis of monogenic as well as atypical forms of diabetes mellitus has
important clinical implications for their specific diagnosis, prognosis, and targeted treatment …

Monogenic diabetes consists of different subtypes of single gene disorders comprising a
large spectrum of phenotypes, namely neonatal diabetes mellitus or monogenic diabetes of …

At present, outside of infancy, genetic testing for monogenic diabetes is typically for
mutations in maturity-onset diabetes of the young (MODY) genes that predominantly result in …

Introduction Monogenic diabetes, a form of diabetes mellitus, is caused by a mutation in a
single gene and may account for 1–2% of all clinical forms of diabetes. To date, more than …

Monogenic diabetes refers to diabetes mellitus (DM) caused by a mutation in a single gene
and accounts for approximately 1%–5% of diabetes. Correct diagnosis is clinically critical for …

Monogenic diabetes includes several clinical conditions generally characterized by early-
onset diabetes, such as neonatal diabetes, maturity-onset diabetes of the young (MODY) …